BIOVECTRA

📍 Charlottetown, Canada🗓 Founded 1970👥 487 employees💰 Last funded Nov 2019
Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision reality, is at the heart of our organization. We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for: Synthetic small molecules Fermented small molecules Highly potent APIs Biologics Bioreagents Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We assure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1970
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BIOVECTRA?
BIOVECTRA has 1 investors on record on gritt.io.
When did BIOVECTRA last raise funding?
The most recent investment in BIOVECTRA recorded on gritt.io was in November 2019.
When was BIOVECTRA founded?
BIOVECTRA was founded in 1970.
What industry is BIOVECTRA in?
BIOVECTRA operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is BIOVECTRA based?
BIOVECTRA is headquartered in Charlottetown, Canada.